Literature DB >> 28078436

Adhering to the 2014 WHO terminology on borderline ovarian tumors.

Jaime Prat1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28078436     DOI： 10.1007/s00428-017-2067-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  15 in total

1.  Staging classification for cancer of the ovary, fallopian tube, and peritoneum.

Authors:  Jaime Prat
Journal:  Int J Gynaecol Obstet       Date:  2013-10-22       Impact factor: 3.561

2.  Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.

Authors:  R T Burks; M E Sherman; R J Kurman
Journal:  Am J Surg Pathol       Date:  1996-11       Impact factor: 6.394

Review 3.  The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2016-04       Impact factor: 4.307

4.  Micropapillary pattern in serous borderline ovarian tumors: does it matter?

Authors:  Jeong-Yeol Park; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Kyu-Rae Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  Gynecol Oncol       Date:  2011-09-13       Impact factor: 5.482

Review 5.  Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms.

Authors:  Daichi Maeda; Ie-Ming Shih
Journal:  Adv Anat Pathol       Date:  2013-01       Impact factor: 3.875

6.  Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up.

Authors:  Teri A Longacre; Jesse K McKenney; Henry D Tazelaar; Richard L Kempson; Michael R Hendrickson
Journal:  Am J Surg Pathol       Date:  2005-06       Impact factor: 6.394

7.  Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.

Authors:  Chen Hsuan Wu; Tsui-Lien Mao; Russell Vang; Ayse Ayhan; Tian-Li Wang; Robert J Kurman; Ie-Ming Shih
Journal:  Int J Gynecol Pathol       Date:  2012-07       Impact factor: 2.762

Review 8.  Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features.

Authors:  Jaime Prat
Journal:  Virchows Arch       Date:  2012-02-10       Impact factor: 4.064

9.  Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome.

Authors:  Stefanie Avril; Ellen Hahn; Katja Specht; Steffen Hauptmann; Cornelia Höss; Marion Kiechle; Heinz Höfler; Barbara Schmalfeldt
Journal:  Gynecol Oncol       Date:  2012-09-18       Impact factor: 5.482

10.  Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion.

Authors:  Jaime Prat; Michele De Nictolis
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394
View more
  1 in total

1.  Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung.

Authors:  Javier Del Aguila Mejía; Subasri Armon; Fiona Campbell; Richard Colling; Magdalena Chechlinska; Magdalena Kowalewska; Marina Pollán; Stefan Holdenrieder; Puay Hoon Tan; Ian Cree; Blanca Iciar Indave Ruiz
Journal:  BMJ Open       Date:  2022-10-11       Impact factor: 3.006
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.